Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Filed by AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2025
Income
Not reported
Expenses
$210,000.00
Filing UUID
c1d45956-7a4d-4952-9749-c077943331e3
Termination date
Not reported

Expense method: C

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Support for H.R. 879, the bipartisan Medicare Patient Access and Practice Stabilization Act, which would halt the 2.83 percent Medicare physician payment cut and provide a 6.62 percent update through the end of the year to address inflationary pressures. Support for including language in HR 1 to halt the current year cuts and provide long-term reform to the Medicare physician payment system. Concerns about medicaid-related provisions in HR 1.

Literal federal measure citations: H.R. 879, HR 1, HR 1

INS · Insurance

Support for the Dental and Optometric Care (DOC) Access Act (HR 1521), which would prohibit dental and vision plans from capping fees on non-covered services Support for reintroduction of the Ensuring Lasting Smiles Act (S 1677/HR 3277), which would require health insurers to cover treatment, including dental, for patients with congenital craniofacial anomalies.

Literal federal measure citations: HR 1521, S 1677, HR 3277

EDU · Education

Support for the Resident Education Deferred (REDI) Act (HR 2028/S 942), which would allow physicians and dentists to defer their student loans interest free during residency. Support for H.R. 1758, the Dental Loan Repayment Assistance Act, which would allow full-time dental faculty members participating in the Health Resources and Services Administrations (HRSA) Dental Faculty Loan Repayment Program (DFLRP) to exclude from income the amount of their loan forgiveness from their federal income taxes. Opposing student loan reforms in the One Big Beautiful Bill Act (HR 1) -specifically the elimination of the Grad Plus Loan program, the implementation of federal loan caps and the prohibition of time spent in medical and dental residency from counting toward public service loan forgiveness (PSLF).

Literal federal measure citations: HR 2028, S 942, H.R. 1758, HR 1

HCR · Health Issues

Support for the RAPID Reserve Act (S 2062/HR 3955), which aims to address drug shortages by awarding federal contracts to American-based manufacturers of generic drugs to encourage domestic production of these critical medications as well as incentivize them to increase their reserves in preparation for possible future public health threats or supply chain challenges and ramp up their production capacity if necessary to proactively prevent shortages. Support for the Mapping Americas Pharmaceutical Supply or MAPS Act (S 1784/HR 4191), which seeks conduct a risk assessment and supply chain map of all essential medicines to help identify vulnerabilities and potential national security risks. Support for the reintroduction of the following drug and supply bills from the 118th Congress: The Drug Shortages Prevention and Quality Improvement Act, which aimed to implement reimbursement models to incentivize the production of generic injectables and extend expiration dates for lifesaving medications. Support for legislation to reauthorize the Dr. Lorna Breen Health Care Provider Protection Act (H.R. 929/S. 266), which provides funding for programs that support mental healthcare for healthcare providers. Ask the DOD to maintain current water fluoridation levels on overseas bases. Suggestions for deregulation within federal healthcare programs. Support for the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act (H.R. 1227/S. 475)

Literal federal measure citations: S 2062, HR 3955, S 1784, HR 4191, H.R. 929, S. 266, H.R. 1227, S. 475

TAX · Taxation/Internal Revenue Code

Support for the extension of several small business tax reductions and opposition to the removal of the pass-through entity tax deduction in the One Big Beautiful Bill Act (HR 1)

Literal federal measure citations: HR 1

TAR · Tariff (miscellaneous tariff bills)

Opposition to potential U.S. tariffs on pharmaceutical drugs and active pharmaceutical ingredients (APIs).

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.